Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04138381
What this trial is testing

Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)

Who this might be right for
Maximum Tolerated DoseGISTMetastatic Adult Soft Tissue Sarcoma+2 more
Grupo Espanol de Investigacion en Sarcomas 30
Not applicableLooking for participantsNCT06875700
What this trial is testing

Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients

Who this might be right for
Leiomyosarcoma
University of Utah 300
Testing effectiveness (Phase 2)Study completedNCT03526679
What this trial is testing

Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaLiposarcomaSoft Tissue Sarcoma Adult+1 more
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00357396
What this trial is testing

Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 10
Not applicableNot Yet RecruitingNCT07723235
What this trial is testing

Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
Ohio State University Comprehensive Cancer Center 90
Not applicableUnknownNCT05057143
What this trial is testing

3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

Who this might be right for
Tumor of BoneChest Wall TumorChest Wall Sarcoma+3 more
Blokhin's Russian Cancer Research Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT00508443
What this trial is testing

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

Who this might be right for
Spinal Neoplasms
M.D. Anderson Cancer Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT04305548
What this trial is testing

Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Who this might be right for
Mesenchymal Chondrosarcoma
Italian Sarcoma Group 16
Early research (Phase 1)Ended earlyNCT00976508
What this trial is testing

Figitumumab Combined With Pegvisomant For Advanced Solid Tumors

Who this might be right for
Colorectal NeoplasmsLung NeoplasmsBreast Neoplasms+2 more
Pfizer 24
Not applicableStudy completedNCT03542097
What this trial is testing

Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan

Who this might be right for
Ewing Sarcoma Family of Tumors
Istituto Ortopedico Rizzoli 82
Not applicableLooking for participantsNCT06029218
What this trial is testing

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

Who this might be right for
ChordomaChondrosarcomaEwing Sarcoma+1 more
Centre Antoine Lacassagne 106
Testing effectiveness (Phase 2)Study completedNCT00019123
What this trial is testing

Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02239861
What this trial is testing

TAA-Specific CTLS for Solid Tumors (TACTASOM)

Who this might be right for
Rhabdomyosarcoma
Baylor College of Medicine 16
Testing effectiveness (Phase 2)Looking for participantsNCT07028086
What this trial is testing

VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma

Who this might be right for
Acute Myeloid LeukemiaMyeloid Sarcoma
Ruijin Hospital 48
Not applicableStudy completedNCT05631379
What this trial is testing

Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma

Who this might be right for
Retroperitoneal SarcomaBody CompositionMalnutrition+3 more
Institute of Oncology Ljubljana 100
Testing effectiveness (Phase 2)Looking for participantsNCT06778603
What this trial is testing

B7-H3 NIR Imaging for Osteosarcoma Surgery

Who this might be right for
OsteosarcomaResection MarginsB7-H3 Probe+1 more
Peking University People's Hospital 32
Early research (Phase 1)Study completedNCT00003023
What this trial is testing

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT05193188
What this trial is testing

Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Who this might be right for
Chondrosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 70
Testing effectiveness (Phase 2)Looking for participantsNCT04072042
What this trial is testing

BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05019703
What this trial is testing

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Who this might be right for
Locally Advanced OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma+2 more
M.D. Anderson Cancer Center 40
Next Page